Clinical Trial Update: A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dasatinib or imatinib in combination with chemotherapy and blinatumomab for pediatric, adolescent, and young adult Philadelphi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)
• Gleevec (Imatinib)
• Sprycel (dasatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING